Stay updated on Nivolumab Combo Immuno-therapy Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo Immuno-therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo Immuno-therapy Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The study’s listed Czech location “Olomoucký kraj” has been replaced with “Olomouc Region,” keeping the same city/region and postal code. A minor site revision string was also updated from “Revision: v3.5.2” to “Revision: v3.5.3.”
    Difference
    0.1%
    Check dated 2026-04-24T06:39:33.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:49:18.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Updated the Italian site from Padua to Padova (35128) to reflect the local naming.
    Difference
    0.0%
    Check dated 2026-04-09T21:43:55.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. This indicates a new page revision/version.
    Difference
    0.0%
    Check dated 2026-03-19T06:16:34.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T02:27:52.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2, and the earlier funding lapse notice (Revision: v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T11:41:03.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo Immuno-therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo Immuno-therapy Clinical Trial page.